Treats uncomplicated malaria due to Plasmodium falciparum, Plasmodium malariae…. ANDA 40766, held by Ipca Labs Ltd. Hydroxychloroquine Sulfate.
As of Nov 15, 2026, ANDA 40766 (Hydroxychloroquine Sulfate), held by Ipca Labs Ltd, was first approved by FDA on Jun 14, 2007, with 7 approved supplements and 0 published complete response letters.
Hydroxychloroquine sulfate is an antimalarial and antirheumatic indicated for the: Treatment of uncomplicated malaria due to Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodium vivax in adult and pediatric patients. Prophylaxis of malaria in geographic areas where chloroquine resistance is not reported in adult and pediatric patients. Treatment of rheumatoid arthritis in adults. Treatment of systemic lupus erythematosus in adults. Treatment of chronic discoid lupus erythematosus in adults. Limitations of Use: Hydroxychloroquine sulfate is not recommended for the: Treatment of complicated malaria.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 14, 2007 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydroxychloroquine Sulfate200MG · tablet;oral | Hydroxychloroquine Sulfate | Rx |
| Jan 24, 2024 | Supplement 27Labeling · Standard review | Approved | None posted |
| Jan 24, 2024 | Supplement 24Labeling · Standard review | Approved | None posted |
| Nov 10, 2022 | Supplement 21Labeling · Standard review | Approved | None posted |
| Nov 10, 2022 | Supplement 20Labeling · Standard review | Approved | None posted |
| Aug 23, 2021 | Supplement 18Labeling · Standard review | Approved | None posted |
| Mar 31, 2020 | Supplement 13Labeling · Standard review | Approved | |
| Feb 20, 2008 | Supplement 2Labeling | Approved | None posted |
| Jun 14, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters